| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbadc41aa91592752369d88100f96411 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
1989-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61cb8f6868e73773377a112004d7ee85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25140f2b2fdd77f2178df4a3db637ef0 |
| publicationDate |
1989-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-8908461-A1 |
| titleOfInvention |
Interferon gamma composition to suppress immune system |
| abstract |
An improved method is provided that allows the continued administration of monoclonal antibodies in immunotherapy and immunodiagnosis. The procedure avoids the problem of anti-monoclonal sensitization by using interferon-gamma as an immunosuppressive agent prior to, and/or during, the course of treatment with monoclonal antibody. Further, an interferon-gamma composition is set forth employing an amount sufficient to suppress the patient's immune response, useful for patients undergoing immunodiagnostic or immunotherapeutic procedures. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9904814-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0893124-A1 |
| priorityDate |
1988-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |